{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:53:28Z","timestamp":1791294808589,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":2623,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["13PRE17030004"],"award-info":[{"award-number":["13PRE17030004"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1111\/jth.13033","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T03:43:18Z","timestamp":1434339798000},"page":"1545-1556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy"],"prefix":"10.1016","volume":"13","author":[{"given":"S.","family":"Absar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13033_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/cmmi.1521","article-title":"SPECT imaging of fibrin using fibrin\u2010binding peptides","volume":"8","author":"Starmans","year":"2013","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1111\/jth.13033_bb0015","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.2174\/0929867311320220004","article-title":"Platelets and atherothrombosis: causes, targets and treatments for thrombosis","volume":"20","author":"Siddiqui","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1111\/jth.13033_bb0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/1741826711415707","article-title":"Trends in acute myocardial infarction treatment between 1998 and 2007 in a Belgian area (Charleroi)","volume":"19","author":"Collart","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1111\/jth.13033_bb0025","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4103\/1673-5374.137580","article-title":"Targeted thrombolysis strategies for neuroprotective effect","volume":"9","author":"Zhang","year":"2014","journal-title":"Neural Regen Res"},{"key":"10.1111\/jth.13033_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0168-3659(01)00493-X","article-title":"Device\u2010directed therapeutic drug delivery systems","volume":"78","author":"Matsuda","year":"2002","journal-title":"J Control Release"},{"key":"10.1111\/jth.13033_bb0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncpcardio0378","article-title":"Technology insight: an overview of research in drug\u2010eluting stents","volume":"2","author":"Ong","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1111\/jth.13033_bb0040","first-page":"48","article-title":"Novel and emerging therapies: thrombus\u2010targeted fibrinolysis","volume":"39","author":"Lippi","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13033_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/bi00376a002","article-title":"Functional role of proteolytic cleavage at arginine\u2010275 of human tissue plasminogen activator as assessed by site\u2010directed mutagenesis","volume":"26","author":"Tate","year":"1987","journal-title":"Biochemistry"},{"key":"10.1111\/jth.13033_bb0050","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/S0021-9258(19)81052-9","article-title":"Fibrinolytic properties of one\u2010chain and two\u2010chain human extrinsic (tissue\u2010type) plasminogen activator","volume":"257","author":"Rijken","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13033_bb0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/clc.4960130602","article-title":"Future directions in plasminogen activator therapy","volume":"13","author":"Bode","year":"1990","journal-title":"Clin Cardiol"},{"key":"10.1111\/jth.13033_bb0060","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.96.3.761","article-title":"Clearance of tissue plasminogen activator (TPA) and TPA\/plasminogen activator inhibitor type 1 (PAI\u20101) complex: relationship to elevated TPA antigen in patients with high PAI\u20101 activity levels","volume":"96","author":"Chandler","year":"1997","journal-title":"Circulation"},{"key":"10.1111\/jth.13033_bb0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/bj2380643","article-title":"Clearance of the heavy and light polypeptide chains of human tissue\u2010type plasminogen activator in rats","volume":"238","author":"Rijken","year":"1986","journal-title":"Biochem J"},{"key":"10.1111\/jth.13033_bb0070","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0021-9258(19)77918-6","article-title":"A tissue\u2010type plasminogen activator mutant with prolonged clearance in\u00a0vivo. Effect of removal of the growth factor domain","volume":"263","author":"Browne","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13033_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/protein\/5.1.93","article-title":"Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t\u2010PA deletion variant BM 06.022","volume":"5","author":"Kohnert","year":"1992","journal-title":"Protein Eng"},{"key":"10.1111\/jth.13033_bb0080","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1073\/pnas.91.9.3670","article-title":"A faster\u2010acting and more potent form of tissue plasminogen activator","volume":"91","author":"Keyt","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13033_bb0085","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1161\/01.CIR.92.10.3032","article-title":"New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA","volume":"92","author":"Benedict","year":"1995","journal-title":"Circulation"},{"key":"10.1111\/jth.13033_bb0090","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1073\/pnas.96.16.8879","article-title":"A catalytic switch and the conversion of streptokinase to a fibrin\u2010targeted plasminogen activator","volume":"96","author":"Reed","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13033_bb0095","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1538-7836.2009.03491.x","article-title":"Reprogrammed streptokinases develop fibrin\u2010targeting and dissolve blood clots with more potency than tissue plasminogen activator","volume":"7","author":"Sazonova","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0100","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1021\/bi00389a011","article-title":"A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin\u2010binding and tissue plasminogen activator catalytic domains","volume":"26","author":"Robbins","year":"1987","journal-title":"Biochemistry"},{"key":"10.1111\/jth.13033_bb0105","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1016\/S0021-9258(18)61043-9","article-title":"Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue\u2010type plasminogen activator and amino acids 144 to 411 of urokinase\u2010type plasminogen activator","volume":"262","author":"Nelles","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13033_bb0110","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1073\/pnas.84.19.6904","article-title":"Construction and expression of a recombinant antibody\u2010targeted plasminogen activator","volume":"84","author":"Schnee","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13033_bb0115","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.1073\/pnas.88.22.10337","article-title":"A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in\u00a0vitro and in\u00a0vivo","volume":"88","author":"Runge","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13033_bb0120","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/01.CIR.94.6.1412","article-title":"Enhanced thrombolytic and antithrombotic potency of a fibrin\u2010targeted plasminogen activator in baboons","volume":"94","author":"Runge","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/jth.13033_bb0125","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.CIR.101.10.1158","article-title":"Construction and functional evaluation of a single\u2010chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa","volume":"101","author":"Peter","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/jth.13033_bb0130","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1538-7836.2004.00697.x","article-title":"Construction and characterization of a\u00a0recombinant plasminogen activator composed of an anti\u2010fibrin\u00a0single\u2010chain antibody and low\u2010molecular\u2010weight urokinase","volume":"2","author":"Hagemeyer","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0135","doi-asserted-by":"crossref","first-page":"19717","DOI":"10.1016\/S0021-9258(18)55051-1","article-title":"Characterization of a chimeric plasminogen activator consisting of a single\u2010chain Fv fragment derived from a fibrin fragment D\u2010dimer\u2010specific antibody and a truncated single\u2010chain urokinase","volume":"266","author":"Holvoet","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13033_bb0140","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1432-1033.1992.tb17499.x","article-title":"Biochemical characterization of single\u2010chain chimeric plasminogen activators consisting of a single\u2010chain Fv fragment of a fibrin\u2010specific antibody and single\u2010chain urokinase","volume":"210","author":"Holvoet","year":"1992","journal-title":"Eur J Biochem"},{"key":"10.1111\/jth.13033_bb0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0038-1656344","article-title":"Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D\u2010dimer specific humanized monoclonal antibody and a truncated single\u2010chain urokinase","volume":"68","author":"Dewerchin","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0150","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1016\/S0021-9258(18)61037-3","article-title":"Characterization of an antibody\u2013urokinase conjugate. A plasminogen activator targeted to fibrin","volume":"262","author":"Bode","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13033_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-2828(87)80578-3","article-title":"Thrombolysis by a fibrin\u2010specific antibody Fab\u2032\u2013urokinase conjugate","volume":"19","author":"Bode","year":"1987","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/jth.13033_bb0160","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.81.6.1974","article-title":"Conjugation to antifibrin Fab\u2032 enhances fibrinolytic potency of single\u2010chain urokinase plasminogen activator","volume":"81","author":"Bode","year":"1990","journal-title":"Circulation"},{"key":"10.1111\/jth.13033_bb0165","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1073\/pnas.84.21.7659","article-title":"Antibody\u2010enhanced thrombolysis: targeting of tissue plasminogen activator in\u00a0vivo","volume":"84","author":"Runge","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13033_bb0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1749-6632.1983.tb23261.x","article-title":"The occurrence and clinical relevance of fibrin fragments in blood","volume":"408","author":"Gaffney","year":"1983","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/jth.13033_bb0175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0038-1646582","article-title":"Binding properties of monoclonal antibodies against human fragment D\u2010dimer of cross\u2010linked fibrin to human plasma clots in an in\u00a0vivo model in rabbits","volume":"61","author":"Holvoet","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/bc00011a001","article-title":"Enhancement of the thrombolytic potency of plasminogen activators by conjugation with clot\u2010specific monoclonal antibodies","volume":"2","author":"Dewerchin","year":"1991","journal-title":"Bioconjug Chem"},{"key":"10.1111\/jth.13033_bb0185","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/0735-1097(90)90327-L","article-title":"Lysis of plasminogen activator\u2010resistant platelet\u2010rich coronary artery thrombus with combined bolus injection of recombinant tissue\u2010type plasminogen activator and antiplatelet GPIIb\/IIIa antibody","volume":"16","author":"Yasuda","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.13033_bb0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1432-1033.1991.tb15699.x","article-title":"Construction and characterization of a functional chimeric murine\u2013human antibody directed against human fibrin fragment\u2010D dimer","volume":"195","author":"Bulens","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1111\/jth.13033_bb0195","doi-asserted-by":"crossref","first-page":"16343","DOI":"10.1016\/S0021-9258(18)55303-5","article-title":"Characterization of a recombinant single\u2010chain molecule comprising the variable domains of a monoclonal antibody specific for human fibrin fragment D\u2010dimer","volume":"266","author":"Laroche","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13033_bb0200","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood.V78.4.1005.1005","article-title":"Effect of chemical conjugation of recombinant single\u2010chain urokinase\u2010type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in\u00a0vitro and in\u00a0vivo","volume":"78","author":"Dewerchin","year":"1991","journal-title":"Blood"},{"key":"10.1111\/jth.13033_bb0205","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.CIR.84.2.805","article-title":"Platelet\u2010targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation","volume":"84","author":"Bode","year":"1991","journal-title":"Circulation"},{"key":"10.1111\/jth.13033_bb0210","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.ATV.13.12.1837","article-title":"A chimeric murine\/human antibody Fab fragment directed against the platelet GPIIb\/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue\u2010type plasminogen activator in baboons","volume":"13","author":"Kohmura","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1111\/jth.13033_bb0215","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCRESAHA.114.302514","article-title":"Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody\u2010targeted recombinant plasminogen activator directed against activated platelets","volume":"114","author":"Wang","year":"2014","journal-title":"Circ Res"},{"key":"10.1111\/jth.13033_bb0220","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1073\/pnas.70.9.2663","article-title":"Enzyme loading of erythrocytes","volume":"70","author":"Ihler","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13033_bb0225","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nbt846","article-title":"Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA\u2010carrying erythrocytes","volume":"21","author":"Murciano","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1111\/jth.13033_bb0230","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.104.075770","article-title":"Blood clearance and activity of erythrocyte\u2010coupled fibrinolytics","volume":"312","author":"Ganguly","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jth.13033_bb0235","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/jpet.106.114405","article-title":"The glycocalyx protects erythrocyte\u2010bound tissue\u2010type plasminogen activator from enzymatic inhibition","volume":"321","author":"Ganguly","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1111\/jth.13033_bb0240","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1182\/blood-2005-11-012336","article-title":"Human complement receptor type 1\u2010directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis","volume":"108","author":"Zaitsev","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13033_bb0245","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/CIRCULATIONAHA.107.750257","article-title":"Cerebrovascular thromboprophylaxis in mice by erythrocyte\u2010coupled tissue\u2010type plasminogen activator","volume":"118","author":"Danielyan","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.13033_bb0250","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/jpet.109.159194","article-title":"Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis","volume":"332","author":"Zaitsev","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jth.13033_bb0255","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1182\/blood-2010-01-261610","article-title":"Sustained thromboprophylaxis mediated by an RBC\u2010targeted pro\u2010urokinase zymogen activated at the site of clot formation","volume":"115","author":"Zaitsev","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13033_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/protein\/3.2.117","article-title":"Structure\u2013function analysis of tissue\u2010type plasminogen activator by linker\u2010insertion, point and deletion mutagenesis","volume":"3","author":"Markland","year":"1989","journal-title":"Protein Eng"},{"key":"10.1111\/jth.13033_bb0265","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1642708","article-title":"Fibrinolytic agents: mechanisms of activity and pharmacology","volume":"74","author":"Lijnen","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3181\/00379727-192-42995","article-title":"Thrombolysis using liposomal\u2010encapsulated streptokinase: an in\u00a0vitro study","volume":"192","author":"Nguyen","year":"1989","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/jth.13033_bb0275","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.RES.66.3.875","article-title":"Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase","volume":"66","author":"Nguyen","year":"1990","journal-title":"Circ Res"},{"key":"10.1111\/jth.13033_bb0280","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10611869509015959","article-title":"The preparation of tissue\u2010type plasminogen activator (t\u2010PA) containing liposomes: entrapment efficiency and ultracentrifugation damage","volume":"3","author":"Heeremans","year":"1995","journal-title":"J Drug Target"},{"key":"10.1111\/jth.13033_bb0285","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-0038-1653802","article-title":"Thrombolytic treatment with tissue\u2010type plasminogen activator (t\u2010PA) containing liposomes in rabbits: a comparison with free t\u2010PA","volume":"73","author":"Heeremans","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0290","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1055\/s-0038-1656133","article-title":"Streptokinase entrapment in interdigitation\u2010fusion liposomes improves thrombolysis in an experimental rabbit model","volume":"77","author":"Perkins","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0295","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0037-1613600","article-title":"Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome\u2010encapsulated and microencapsulated streptokinase","volume":"90","author":"Leach","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0300","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1517\/17425240802497457","article-title":"Liposomes for targeted delivery of antithrombotic drugs","volume":"5","author":"Elbayoumi","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1111\/jth.13033_bb0305","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02975283","article-title":"Prolonged systemic delivery of streptokinase using liposome","volume":"21","author":"Kim","year":"1998","journal-title":"Arch Pharm Res"},{"key":"10.1111\/jth.13033_bb0310","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1160\/TH03-11-0704","article-title":"Encapsulation of a plasminogen activator speeds reperfusion, lessens infarct and reduces blood loss in a canine model of coronary artery thrombosis","volume":"91","author":"Leach","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/bit.260480203","article-title":"Enzyme\u2010mediated proteolysis of fibrous biopolymers: dissolution front movement in fibrin or collagen under conditions of diffusive or convective transport","volume":"48","author":"Anand","year":"1995","journal-title":"Biotechnol Bioeng"},{"key":"10.1111\/jth.13033_bb0320","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1538-7836.2004.00884.x","article-title":"Distributed intraclot thrombolysis: mechanism of accelerated thrombolysis with encapsulated plasminogen activators","volume":"2","author":"Leach","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0325","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.biomaterials.2007.09.027","article-title":"Accelerating thrombolysis with chitosan\u2010coated plasminogen activators encapsulated in poly\u2010(lactide\u2010co\u2010glycolide) (PLGA) nanoparticles","volume":"29","author":"Chung","year":"2008","journal-title":"Biomaterials"},{"key":"10.1111\/jth.13033_bb0330","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-3659(01)00505-3","article-title":"Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery","volume":"78","author":"Lestini","year":"2002","journal-title":"J Control Release"},{"key":"10.1111\/jth.13033_bb0335","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1160\/TH04-06-0340","article-title":"RGD\u2010modified liposomes targeted to activated platelets as a potential vascular drug delivery system","volume":"93","author":"Gupta","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0340","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.biomaterials.2007.12.015","article-title":"Affinity manipulation of surface\u2010conjugated RGD peptide to modulate binding of liposomes to activated platelets","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1111\/jth.13033_bb0345","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/jbm.a.32549","article-title":"In vitro and in\u00a0vivo platelet targeting by cyclic RGD\u2010modified liposomes","volume":"93","author":"Srinivasan","year":"2010","journal-title":"J Biomed Mater Res A"},{"key":"10.1111\/jth.13033_bb0350","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1110\/ps.8.12.2663","article-title":"Structure of the fibrinogen gamma\u2010chain integrin binding and factor XIIIa cross\u2010linking sites obtained through carrier protein driven crystallization","volume":"8","author":"Ware","year":"1999","journal-title":"Protein Sci"},{"key":"10.1111\/jth.13033_bb0355","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-013-1011-x","article-title":"Thrombus\u2010targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy","volume":"30","author":"Absar","year":"2013","journal-title":"Pharm Res"},{"key":"10.1111\/jth.13033_bb0360","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1016\/j.biomaterials.2009.02.034","article-title":"Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid\u2010coated nanoparticles","volume":"30","author":"Ma","year":"2009","journal-title":"Biomaterials"},{"key":"10.1111\/jth.13033_bb0365","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1118\/1.3271344","article-title":"Particle size, magnetic field, and blood velocity effects on particle retention in magnetic drug targeting","volume":"37","author":"Cherry","year":"2010","journal-title":"Med Phys"},{"key":"10.1111\/jth.13033_bb0370","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1016\/j.biomaterials.2010.07.107","article-title":"The use of magnetite nanoparticles for implant\u2010assisted magnetic drug targeting in thrombolytic therapy","volume":"31","author":"Kempe","year":"2010","journal-title":"Biomaterials"},{"key":"10.1111\/jth.13033_bb0375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2004.07.020","article-title":"Application of \u2018ATTEMPTS\u2019 for drug delivery","volume":"101","author":"Naik","year":"2005","journal-title":"J Control Release"},{"key":"10.1111\/jth.13033_bb0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-3659(01)00484-9","article-title":"ATTEMPTS: a heparin\/protamine\u2010based delivery system for enzyme drugs","volume":"78","author":"Liang","year":"2002","journal-title":"J Control Release"},{"key":"10.1111\/jth.13033_bb0385","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/jbm.a.34916","article-title":"Serum albumin\u2013protamine conjugate for biocompatible platform for targeted delivery of therapeutic macromolecules","volume":"102","author":"Absar","year":"2014","journal-title":"J Biomed Mater Res A"},{"key":"10.1111\/jth.13033_bb0390","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.thromres.2012.11.030","article-title":"Preparation and characterization of anionic oligopeptide\u2010modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis","volume":"131","author":"Absar","year":"2013","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13033_bb0395","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2011.09.060","article-title":"Heparin\u2010triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis","volume":"157","author":"Absar","year":"2012","journal-title":"J Control Release"},{"key":"10.1111\/jth.13033_bb0400","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1056\/NEJMoa041175","article-title":"Ultrasound\u2010enhanced systemic thrombolysis for acute ischemic stroke","volume":"351","author":"Alexandrov","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13033_bb0405","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10611860601140673","article-title":"Fibrin targeting of tissue plasminogen activator\u2010loaded echogenic liposomes","volume":"15","author":"Tiukinhoy\u2010Laing","year":"2007","journal-title":"J Drug Target"},{"key":"10.1111\/jth.13033_bb0410","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.thromres.2007.07.006","article-title":"Ultrasound\u2010enhanced tissue plasminogen activator thrombolysis in an in\u00a0vitro porcine clot model","volume":"121","author":"Holland","year":"2008","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13033_bb0415","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.thromres.2006.06.009","article-title":"Ultrasound\u2010facilitated thrombolysis using tissue\u2010plasminogen activator\u2010loaded echogenic liposomes","volume":"119","author":"Tiukinhoy\u2010Laing","year":"2007","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13033_bb0420","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2012.08.1008","article-title":"A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound","volume":"60","author":"Kawata","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.13033_bb0425","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/1061186X.2011.633259","article-title":"Ultrasound\u2010responsive thrombus treatment with zinc\u2010stabilized gelatin nano\u2010complexes of tissue\u2010type plasminogen activator","volume":"20","author":"Uesugi","year":"2012","journal-title":"J Drug Target"},{"key":"10.1111\/jth.13033_bb0430","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2010.07.127","article-title":"An ultrasound\u2010responsive nano delivery system of tissue\u2010type plasminogen activator for thrombolytic therapy","volume":"147","author":"Uesugi","year":"2010","journal-title":"J Control Release"},{"key":"10.1111\/jth.13033_bb0435","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2013.12.036","article-title":"Bio\u2010responsive delivery of tissue plasminogen activator for localized thrombolysis","volume":"177C","author":"Absar","year":"2014","journal-title":"J Control Release"},{"key":"10.1111\/jth.13033_bb0440","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1538-7836.2009.03701.x","article-title":"Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential","volume":"8","author":"Marder","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0445","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3324\/haematol.2011.050492","article-title":"Thrombolytic therapy for central venous catheter occlusion","volume":"97","author":"Baskin","year":"2012","journal-title":"Haematologica"},{"key":"10.1111\/jth.13033_bb0450","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1179\/174313209X393933","article-title":"Hemorrhagic profile of the fibrinolytic alfimeprase after ischemia and reperfusion","volume":"31","author":"Lu","year":"2009","journal-title":"Neurol Res"},{"key":"10.1111\/jth.13033_bb0455","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1538-7836.2003.00128.x","article-title":"Thrombolytic potency of acid\u2010stabilized plasmin: superiority over tissue\u2010type plasminogen activator in an in\u00a0vitro model of catheter\u2010assisted thrombolysis","volume":"1","author":"Novokhatny","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0460","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-0037-1616127","article-title":"Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit","volume":"86","author":"Marder","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0465","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1161\/01.STR.0000230307.03438.94","article-title":"Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke","volume":"37","author":"Marder","year":"2006","journal-title":"Stroke"},{"key":"10.1111\/jth.13033_bb0470","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1538-7836.2008.02969.x","article-title":"A first\u2010in\u2010human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion","volume":"6","author":"Shlansky\u2010Goldberg","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13033_bb0475","unstructured":"Saver J. A safety and dose finding study of plasmin (human) administered into the middle cerebral artery of stroke patients. http:\/\/clinicaltrials.gov\/show\/NCT01014975, 2009."},{"key":"10.1111\/jth.13033_bb0480","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12975-014-0376-4","article-title":"Plasmin\u2010loaded echogenic liposomes for ultrasound\u2010mediated thrombolysis","volume":"6","author":"Kandadai","year":"2015","journal-title":"Transl Stroke Res"},{"key":"10.1111\/jth.13033_bb0485","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent\u2010retriever thrombectomy after intravenous t\u2010PA vs. t\u2010PA alone in stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13033_bb0490","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion\u2010imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13033_bb0495","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13033_bb0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13033","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622034298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622034298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13033\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:12:00Z","timestamp":1761534720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622034298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":99,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1538783622034298"],"URL":"https:\/\/doi.org\/10.1111\/jth.13033","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}